Jelena Stanarcic Gajovic
Overview
Explore the profile of Jelena Stanarcic Gajovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milicic T, Jotic A, Lalic K, Lukic L, Macesic M, Stanarcic Gajovic J, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004639
: Previous studies reported impairments in insulin secretion during different stages of type 1 diabetes (T1D), while data regarding insulin sensitivity and immunological changes are still controversial. We analyzed the...
2.
Lalic N, Jotic A, Lukic L, Milicic T, Macesic M, Stanarcic Gajovic J, et al.
Diabetes Res Clin Pract
. 2024 Aug;
216:111816.
PMID: 39147102
Aims: This systematic review was aimed to assess the association between magnitude of body weight loss (BWL) in type 2 diabetes (T2D) patients and cardiovascular (CV) risk in CV outcome...
3.
Krako Jakovljevic N, Pavlovic K, Jotic A, Lalic K, Stoiljkovic M, Lukic L, et al.
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34205752
Type 2 diabetes (T2D), one of the most prevalent noncommunicable diseases, is often preceded by insulin resistance (IR), which underlies the inability of tissues to respond to insulin and leads...
4.
Lalic N, Stanarcic Gajovic J, Stoiljkovic M, Rakocevic I, Jotic A, Maggini M, et al.
Ann Ist Super Sanita
. 2021 Apr;
57(1):89-96.
PMID: 33797411
Introduction: Managing non-communicable diseases (NCDs) requires redesigning health care delivery to achieve better coordination of services at all levels of health care. The aim of this study was improving prevention...
5.
Jotic A, Milicic T, Lalic K, Lukic L, Macesic M, Stanarcic Gajovic J, et al.
Diabetes Ther
. 2020 Feb;
11(4):845-858.
PMID: 32060738
Introduction: We evaluated the effectiveness of long-term continuous subcutaneous insulin infusion (CSII) compared with multiple daily insulin (MDI) injections for glycaemic control and variability, hypoglycaemic episodes and maternal/neonatal outcomes in...
6.
Lalic K, Nedeljkovic M, Jotic A, Babic R, Rajkovic N, Popovic L, et al.
Diabetes Res Clin Pract
. 2018 Mar;
139:179-187.
PMID: 29526680
Aims: This study was aimed to compare insulin sensitivity and secretion response, lipoprotein and plasminogen activator inhibitor 1 (PAI-1) levels between the subjects with and without coronary artery endothelial dysfunction...
7.
Seferovic J, Tesic M, Seferovic P, Lalic K, Jotic A, Biering-Sorensen T, et al.
Sci Rep
. 2018 Jan;
8(1):926.
PMID: 29343820
Left ventricular mass index (LVMI) increase has been described in hypertension (HTN), but less is known about its association with type 2 diabetes (T2DM). As these conditions frequently co-exist, we...
8.
Macesic M, Lalic N, Kostic V, Jotic A, Lalic K, Stefanova E, et al.
Curr Vasc Pharmacol
. 2016 Sep;
15(2):158-166.
PMID: 27599805
Background: The growing body of evidence suggests that atherosclerosis risk factors are important in cognitive decline. Objective: To analyse insulin sensitivity, insulin secretion capacity, plasma insulin, adiponectin and lipid levels...
9.
Lukic L, Lalic N, Rajkovic N, Jotic A, Lalic K, Milicic T, et al.
Int J Environ Res Public Health
. 2014 Apr;
11(4):3586-98.
PMID: 24686488
Increased body weight as well as type 2 diabetes (T2D) are found to be associated with increased incidence of hypertension, although the mechanisms facilitating hypertension in T2D or nondiabetic individuals...